EICHOR
● Recruiting
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
Condition: Parkinsons Disease (PD) · Sponsor: BlueRock Therapeutics
About this study
Study BRT-DA01-301 is a Phase 3 multicenter, randomized, sham surgery-controlled, double-blind study to assess efficacy and safety of bemdaneprocel in approximately 102 adults with Parkinson's Disease (PD).
This description comes directly from the study's public registry record.
Talk to the study team
Patient Engagement · 1-877-380-3967 · clinicaltrials@bluerocktx.com
Always discuss trial participation with your own doctor first.
Locations (42)
| Banner Sun Health Research Institute | Sun City, Arizona, United States | Recruiting |
| University of Arkansas for Medical Sciences | Little Rock, Arkansas, United States | Recruiting |
| UCLA NeuroTranslational Research Center | Los Angeles, California, United States | Recruiting |
| UCI Medical Center - Neurology | Orange, California, United States | Recruiting |
| Stanford Neuroscience Health Center | Palo Alto, California, United States | Recruiting |
| University of Colorado Hospital - Neurology Clinic | Aurora, Colorado, United States | Recruiting |
| MedStar Georgetown University Hospital | Washington D.C., District of Columbia, United States | Recruiting |
| Mayo Clinic Jacksonville - Neurology | Jacksonville, Florida, United States | Recruiting |
| University of Miami Health System - Neurology | Miami, Florida, United States | Recruiting |
| USF Parkinson's Disease and Movement Disorders Center | Tampa, Florida, United States | Recruiting |
| Parkinson's Disease and Movement Disorders Center at Northwestern Memorial Hospital | Chicago, Illinois, United States | Recruiting |
| Rush University Medical Center - Neurology | Chicago, Illinois, United States | Recruiting |
+ 30 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06944522